Charles River Laboratories | CRL - Operating Profit



Charles River Laboratories reported $132.33M in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Agilent USD 360M 60M Jul/2025
Align Technology USD 163.03M 31.93M Jun/2025
Bio-Rad Laboratories USD 77.1M 53.4M Jun/2025
Bruker USD 11.9M 19.9M Jun/2025
Cardinal Health USD 629M 101M Jun/2025
Charles River Laboratories USD 132.33M 57.66M Jun/2025
Cigna USD 2.51B 497M Jun/2025
CVS Health USD 2.38B 993M Jun/2025
Danaher USD 760M 523M Jun/2025
Dentsply International USD 111M 48M Jun/2025
Elevance Health USD 2.63B 508M Jun/2025
Galapagos EUR -57027000 101.68M Jun/2025
Hologic USD 260.9M 267.9M Jun/2025
Humana USD 1.1B 916M Jun/2025
Illumina USD 214M 83M Jun/2025
Incyte USD 310.82M 105.66M Jun/2025
IQVIA Holdings USD 556M 64M Jun/2025
Laboratory Of America USD 462.8M 130.4M Jun/2025
Lonza CHF 430M 104M Dec/2024
McKesson USD 1.08B 508M Jun/2025
Merck EUR 1.03B 24M Jun/2025
Mettler Toledo International USD 265.71M 63.77M Jun/2025
Novartis USD 4.86B 201M Jun/2025
Pfizer USD 2.6B 1.06B Jun/2025
Quest Diagnostics USD 438M 92M Jun/2025
Revvity USD 90.76M 18.53M Jun/2025
Thermo Fisher Scientific USD 1.92B 200M Jun/2025
United Therapeutics USD 276.9M 105.9M Jun/2025
UnitedHealth USD 5.15B 3.95B Jun/2025
Waters USD 188.21M 36.47M Jun/2025
West Pharmaceutical Services USD 153.7M 46.7M Jun/2025